Continued Response to One Dose of Nivolumab Complicated by Myasthenic Crisis and Myositis
Open Access
- 1 July 2017
- journal article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 12 (7), e90-e91
- https://doi.org/10.1016/j.jtho.2017.02.024
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Myasthenic crisis and polymyositis induced by one dose of nivolumabCancer Science, 2016
- Myasthenia gravis induced by nivolumab therapy in a patient with non–small‐cell lung cancerMuscle & Nerve, 2016
- Immune-related adverse events with immune checkpoint blockade: a comprehensive reviewEuropean Journal Of Cancer, 2016
- Acetylcholine receptor binding antibody-associated myasthenia gravis and rhabdomyolysis induced by nivolumab in a patient with melanomaJapanese Journal of Clinical Oncology, 2015
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung CancerNew England Journal of Medicine, 2015